Erratum (DOI:10.1016/S1474-4422(07)70107-2);Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study

Lancet Neurology

Volumn 6, Issue 6, 2007, Pages 487-493

  Lovelock, CE ^a   Molyneux, AJ ^a   Rothwell, PM ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

EID: 34248324434     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70205-3     Document Type: Erratum

References (36)

1. Dennis M. Outcome after brain haemorrhage. Cerebrovasc Dis 16 suppl 1 (2003) 9-13
2. You H., and Al-Shahi R. Haemostatic drug therapies for acute primary intracerebral haemorrhage. Cochrane Database Syst Rev 3 (2006) CD005951.
3. Brown R., Whisnant J., Sicks J., O'Fallon W., and Wiebers D. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 27 (1996) 373-380
4. Pajunen P., Paakkonen R., Hamalainen H., et al. Trends in fatal and nonfatal strokes among persons aged 35 to > or =85 years during 1991-2002 in Finland. Stroke 36 (2005) 244-248
5. Lawlor D., Smith G., Leon D., Sterne J., and Ebrahim S. Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. Lancet 360 (2002) 1818-1823
6. Charlton J., Khaw K., Ebrahim S., and Davey Smith G. Cardiovascular diseases. In: Charlton J., and Murphy M. (Eds). The health of adult Britain 1841-1994 vol 2 (1997), The Stationery Office, London 60-75
7. Vinters H., and Gilbert J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14 (1983) 924-928
8. Torn M., Bollen W., van der Meer F., van der Wall E., and Rosendaal F. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 165 (2005) 1527-1532
9. Abbott R., Curb J., Rodriguez B., et al. Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. J Clin Epidemiol 56 (2003) 479-486
10. Rothwell P., Coull A., Giles M., et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363 (2004) 1925-1933
11. Bamford J., Sandercock P., Dennis M., et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 51 (1988) 1373-1380
12. van Swieten J., Koudstaal P., Visser M., Schouten H., and van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988) 604-607
13. Allen C. Clinical diagnosis of the acute stroke syndrome. Q J Med 52 (1983) 515-523
14. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
15. Woo D., Haverbusch M., Sekar P., et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 35 (2004) 1703-1708
16. Hawkins G., Bonita R., Broad J., and Anderson N. Inadequacy of clinical scoring systems to differentiate stroke subtypes in population-based studies. Stroke 26 (1995) 1338-1342
17. Bogousslavsky J., Regli F., Uske A., and Maeder P. Early spontaneous hematoma in cerebral infarct: is primary cerebral hemorrhage overdiagnosed?. Neurology 41 (1991) 837-840
18. Lovelock C., Coull A., Anslow P., et al. Intra-observer variability in the differentiation between primary intracerebral haemorrhage and haemorrhagic transformation of infarction (HTI). Cerebrovasc Dis 21 suppl 4 (2006) 34 (abstract).
19. Sivenius J., Tuomilehto J., Immonen-Raiha P., et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke 35 (2004) 420-425
20. Terent A. Trends in stroke incidence and 10-year survival in Soderhamn, Sweden, 1975-2001. Stroke 34 (2003) 1353-1358
21. Immonen-Raiha P., Sarti C., Tuomilehto J., et al. Eleven-year trends of stroke in Turku, Finland. Neuroepidemiology 22 (2003) 196-203
22. Numminen H., Kotila M., Waltimo O., Aho K., and Kaste M. Declining incidence and mortality rates of stroke in Finland from 1972 to 1991. Results of three population-based stroke registers. Stroke 27 (1996) 1487-1491
23. Benatru I., Rouaud O., Durier J., et al. Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke 37 (2006) 1674-1679
24. Thrift A., McNeil J., Forbes A., and Donnan G. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 31 (1998) 1223-1229
25. Feldmann E., Broderick J., Kernan W., et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 36 (2005) 1881-1885
26. Unal B., Critchley J., and Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109 (2004) 1101-1107
27. Jackson C., and Sudlow C. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?. J Neurol Neurosurg Psychiatry 77 (2006) 1244-1252
28. Hart R., Halperin J., McBride R., Benavente O., Man-Son-Hing M., and Kronmal R. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol 57 (2000) 326-332
29. Hart R., Tonarelli S., and Pearce L. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36 (2005) 1588-1593
30. Flaherty M., Kissela B., Woo D., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68 (2007) 116-121
31. Rosand J., Eckman M., Knudsen K., Singer D., and Greenberg S. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164 (2004) 880-884
32. Saloheimo P., Ahonen M., Juvela S., Pyhtinen J., Savolainen E., and Hillbom M. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 37 (2006) 129-133
33. Itoh Y., Yamada M., Hayakawa M., Otomo E., and Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116 (1993) 135-141
34. Knudsen K., Rosand J., Karluk D., and Greenberg S. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56 (2001) 537-539
35. Segal A., Chiu R., Eggleston-Sexton P., Beiser A., and Greenberg S. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 18 (1999) 185-193
36. Phillips A., and Smith G. The design of prospective epidemiological studies: more subjects or better measurements?. J Clin Epidemiol 46 (1993) 1203-1211